Evox Therapeutics wins funding from Duchenne UK to explore exosome-mediated delivery of dystrophin

November 14, 2018 Leave a comment

Evox Therapeutics, a leading exosome therapeutics company, a leading exosome therapeutics company, today announces that it has secured £655,000 in funding from Duchenne UK. The grant will be invested to support exploration of the Company’s exosome-based therapeutic platform to deliver ...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: Duchenne UK

Evox Therapeutics wins funding from Duchenne UK to explore exosome-mediated delivery of dystrophin

Extracellular vesicles as central regulators of blood vessel function in cancer

Rion Aesthetics’ novel exosome technology validated in clinical study

An integrated microfluidic device for accurate extracellular vesicle quantification and protein markers analysis directly from human whole blood

Extracorporeal blood filter removes circulating tumor cells

Combining single-cell RNA sequencing of peripheral blood mononuclear cells and exosomal transcriptome to reveals the cellular and genetic profiles in COPD

Carnegie Mellon exosome engineering tech licensed to Coya Therapeutics